The use of economic modeling to determine the hospital costs associated with nosocomial infections

Clinical Infectious Diseases

Volumn 36, Issue 11, 2003, Pages 1424-1432

  Roberts, Rebecca R ^a,d   Scott II, R Douglas ^c   Cordell, Ralph ^c   Solomon, Steven L ^c   Steele, Lynn ^c   Kampe, Linda M ^a   Trick, William E ^c   Weinstein, Robert A ^b  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^d Jr Hospital of Cook County   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COST CONTROL; DISEASE SEVERITY; ECONOMIC ASPECT; FEMALE; HOSPITAL COST; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; COHORT STUDIES; COSTS AND COST ANALYSIS; CROSS INFECTION; FEMALE; HOSPITAL COSTS; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; MODELS, ECONOMIC; RETROSPECTIVE STUDIES;

EID: 0038129844     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/375061     Document Type: Article

References (89)

1. Committee on Quality of Health Care in America, Institute of Medicine. To err is human: building a safer health system. Washington, DC: National Academy Press, 2000.
2. Haley RW, Schaberg DR, Von Allmen SD, McGowan JE Jr. Estimating the extra charges and prolongation of hospitalization due to nosocomial infections: a comparison of methods. J Infect Dis 1980; 141:248-57.
3. Haley RW, Culver DH, White JW, Morgan WM, Emori TG. The nationwide nosocomial infection rate: a new need for vital statistics. Am J Epidemiol 1985; 121:159-67.
4. Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Surveillance Report, data summary from January 1996 through December 1997: a report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 1999; 27:279-84.
5. Archibald L, Phillips L, Monnet D, McGowan JE Jr, Tenover F, Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997; 24:211-5.
6. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274:639-44.
7. French GL, Cheng AF, Wong SL, Donnan S. Repeated prevalence surveys for monitoring effectiveness of hospital infection control. Lancet 1989; 2(8670):1021-3.
8. Centers for Disease Control and Prevention. Detailed ICU surveillance component: national nosocomial infection surveillance scheme 1-80. Atlanta, GA: Centers for Disease Control and Prevention, 1997.
9. Niederman MS. Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit Care Med 2001; 29(Suppl 4):N114-20.
10. Lynch JP III. Hospital-acquired pneumonia: risk factors, microbiology, and treatment. Chest 2001; 119(Suppl 2):373S-84S.
11. Flaherty JP, Weinstein RA. Nosocomial infection caused by antibiotic-resistant organisms in the intensive-care unit. Infect Control Hosp Epidemiol 1996; 17:236-48.
12. Souweine B, Traore O, Aublet-Cuvelier B, et al. Role of infection control measures in limiting morbidity associated with multi-resistant organisms in critically ill patients. J Hosp Infect 2000; 45:107-16.
13. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA 1996; 275:234-40.
14. Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985; 121:182-205.
15. Haley RW, White JW, Culver DH, Hughes JM. The financial incentive for hospitals to prevent nosocomial infections under the prospective payment system: an empirical determination from a nationally representative sample. JAMA 1987; 257:1611-4.
16. Fridkin SK, Pear SM, Williamson TH, Galgiani JN, Jarvis WR. The role of understaffing in central venous catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 1996; 17:150-8.
17. Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999; 282:1745-51.
18. Keita-Perse O, Gaynes RP. Severity of illness scoring systems to adjust nosocomial infection rates: a review and commentary. Am J Infect Control 1996; 24:429-34.
19. Montecalvo MA, Jarvis WR, Uman J, et al. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting. Infect Control Hosp Epidemiol 2001; 22:437-42.
20. Graves N, Plowman R, Roberts JA. The epic project: developing national evidence-based guidelines for preventing healthcare associated infections. J Hosp Infect 2001; 48:320-1.
21. Macartney KK, Gorelick MH, Manning ML, Hodinka RL, Bell LM. Nosocomial respiratory syncytial virus infections: the cost-effectiveness and cost-benefit of infection control. Pediatrics 2000; 106:520-6.
22. Veenstra DL, Saint S, Sullivan SD. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 1999; 282:554-60.
23. McGowan JE Jr. Cost and benefit - a critical issue for hospital infection control. Fifth Annual National Foundation for Infectious Diseases Lecture. Am J Infect Control 1982; 10:100-8.
24. Gross PA, Beyt BE Jr, Decker MD, et al. Description of case-mix adjusters by the Severity of Illness Working Group of the Society of Hospital Epidemiologists of America (SHEA). Infect Control Hosp Epidemiol 1988; 9:309-16.
25. Wakefield DS, Helms CM, Massanari RM, Mori M, Pfaller M. Cost of nosocomial infection: relative contributions of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infections. Am J Infect Control 1988; 16:185-92.
26. Pinner RW, Haley RW, Blumenstein BA, Schaberg DR, Von Allmen SD, McGowan JE Jr. High cost nosocomial infections. Infect Control 1982; 3:143-49.
27. Centers for Disease Control and Prevention. Public health focus: surveillance, prevention, and control of nosocomial infections. MMWR Morb Mortal Wldy Rep 1992; 41:783-7.
28. Howard D, Cordell R, McGowan JE Jr, Packard RM, Scott II RD, Solomon SL. Measuring the economic costs of antimicrobial resistance in hospital settings: summary of the Centers for Disease Control and Prevention-Emory Workshop. Clin Infect Dis 2001; 33:1573-8.
29. Rubinstein E, Green M, Modan M, Amit P, Bernstein L, Rubinstein A. The effects of nosocomial infections on the length and costs of hospital stay. J Antimicrob Chemother 1982; 9(Suppl A):93-100.
30. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999; 160:976-81.
31. Rello J, Ochagavia A, Sabanes E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000; 162:1027-30.
32. Girou E, Stephan F, Novara A, Safar M, Fagon JY. Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am J Respir Crit Care Med 1998; 157:1151-8.
33. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999; 20:725-30.
34. Haley RW, Schaberg DR, Crossley KB, Von Allmen SD, McGowan JE Jr. Extra charges and prolongation of stay attributable to nosocomial infections: a prospective interhospital comparison. Am J Med 1981; 70:51-8.
35. Wakefield DS, Pfaller MA, Hammons GT, Massanari RM. Use of the appropriateness evaluation protocol for estimating the incremental costs associated with nosocomial infections. Med Care 1987; 25:481-8.
36. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271:1598-601.
37. Kyne L, Hamel MB, Polavaram R, Kelly CP. Healthcare costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002; 34:346-53.
38. Vernon MO, Trick WE, Peterson BJ, et al. Sustained increase in hand hygiene (HH) associated with decreased antimicrobial resistance (AR) in a long term care facility (LTCF) [abstract 249]. Clin Infect Dis 2001; 33:1131.
39. Schwartz DN, DeMarais P, Steele L, Trick WE, Weinstein RA. Beneficial effect of a training intervention based on IDSA and SHEA guidelines for antibiotic (AB) use in a long term care (LTC) facilities [abstract 490]. Clin Infect Dis 2001; 33:123.
40. Vernon MO, Peterson BJ, Welbel SF, Trick WE, Weinstein RA. Impact of an interactive educational intervention on hand hygiene adherence rates in a multi-center study [abstract K-1331]. In: Programs and abstracts of the 41st Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 2001:424.
41. Glowacki R, Schwartz D, Itokazu G, Wisniewski M, Weinstein RA. Prospective intervention to reduce the use of antibiotic combinations with redundant antimicrobial spectra [abstract O-390]. In: Programs and abstracts of the 41st Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 2001:487.
42. Zagorski BM, Trick WE, Cordell R, Solomon SL, Weinstein RA. Comparison of predictive models to detect central venous catheters [abstract 60]. In: Programs and abstracts of the 12th Annual Meeting of the Society for Healthcare Epidemiology of America (Salt Lake City). 2002: 55.
43. Hooton TM, Haley RW, Culver DH, White JW, Morgan WM, Carroll RJ. The joint associations of multiple risk factors with the occurrence of nosocomial infection. Am J Med 1981; 70:960-70.
44. Pittet D, Thievent B, Wenzel RP, Li N, Gurman G, Suter PM. Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients. Intensive Care Med 1993; 19:265-72.
45. Gross PA, DeMauro PJ, van Anrwerpen C, Wallenstein S, Chiang S. Number of comorbidities as a predictor of nosocomial infection acquisition. Infect Control Hosp Epidemiol 1988; 9:497-500.
46. Hurr H, Hawley HB, Czachor JS, Markert RJ, McCarthy MC. APACHE II and ISS scores as predictors of nosocomial infections in trauma patients. Am J Infect Control 1999; 27:79-83.
47. Gross PA, Stein MR, van Antwerpen C, et al. Comparison of severity of illness indicators in an intensive care unit. Arch Intern Med 1991; 151:2201-5.
48. Salemi C, Morgan J, Padilla S, Morrissey R. Association between severity of illness and mortality from nosocomial infection. Am J Infect Control 1995; 23:188-93.
49. Gaynes RP, Solomon S. Improving hospital-acquired infection rates: the CDC experience. Jt Comm J Qual Improv 1996; 22:457-67.
50. Rello J. Impact of nosocomial infections on outcome: myths and evidence. Infect Control Hosp Epidemiol 1999; 20:392-4.
51. Britt MR, Schleupner CJ, Matsumiya S. Severity of underlying disease as a predictor of nosocomial infection: utility in the control of nosocomial infection. JAMA 1978; 239:1047-51.
52. Bueno-Cavanillas A, Rodriguez-Contreras R, Lopez-Luque A, Delgado-Rodriguez M, Galves-Vargas R. Usefulness of severity indices in intensive care medicine as a predictor of nosocomial infection risk. Intensive Care Med 1991; 17:336-9.
53. Girou E, Pinsard M, Auriant I, Canonne M. Influence of the severity of illness measured by the Simplified Acute Physiology Score (SAPS) on occurrence of nosocomial infections in ICU patients. J Hosp Infect 1996; 34:131-7.
54. Salemi C, Morgan JW, Kelleghan SI, Hiebert-Crape B. Severity of illness classification for infection control departments: a study in nosocomial pneumonia. Am J Infect Control 1993; 21:117-6.
55. Emori TG, Culver DH, Horan TC, et al. National Nosocomial Infections Surveillance System (NNIS): description of surveillance methods. Am J Infect Control 1991; 19:19-35.
56. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100:1619-36.
57. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-83.
58. Bertolini G, D'Amico R, Apolone G, et al. Predicting outcome in the intensive care unit using scoring systems: is new better? A comparison of SAPS and SAPS II in a cohort of 1,393 patients. GiViTi Investigators (Gruppo Italiano per la Valutazione degli interventi in Terapia Intensiva). Simplified Acute Physiology Score. Med Care 1998; 36:1371-82.
59. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-40.
60. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992; 13:606-8.
61. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999; 159:1249-56.
62. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998; 129:433-40.
63. Haley RW, Schaberg DR, McClish DK, et al. The accuracy of retrospective chart review in measuring nosocomial infection rates: results of validation studies in pilot hospitals. Am J Epidemiol 1980; 111: 516-33.
64. Suver JD, Neumann BR, Boles KE. Management accounting for healthcare organizations. 3rd ed. Chicago: Pluribus Press, 1992.
65. Finkler SA. Essentials of cost accounting for health care organizations. Gaithersburg, MD: Aspen, 1994.
66. Roberts RR, Zalenski RJ, Mensah EK, et al. Costs of an emergency department-based accelerated diagnostic protocol vs hospitalization in patients with chest pain: a randomized controlled trial. JAMA 1997; 278:1670-6.
67. Roberts RR, Frutos PW, Ciavarella GG, et al. Distribution of variable vs. fixed costs of hospital care. JAMA 1999; 281:644-9.
68. McDermott MF, Murphy DG, Zalenski RJ, et al. A comparison between emergency diagnostic and treatment unit and inpatient care in the management of acute asthma. Arch Intern Med 1997; 157:2055-62.
69. Studenmund AH. Using econometrics: a practical guide. 4th ed. Boston: Addison, Wesley, Longman, 2001.
70. SAS Institute. SAS statistical software, version 8.1. Cary, NC: SAS Institute, 2002.
71. Hargraves IL, Wilson IB, Zaslavsk, A, et al. Adjusting for patient characteristics when analyzing reports from patients about hospital care. Med Care 2001; 39:635-41.
72. Steen PM, Brewster AC, Bradbury RC, Estabrook E, Young JA. Predicted probabilities of hospital death as a measure of admission severity of illness. Inquiry 1993; 30:128-41.
73. Delgado-Rodriguez M, Sillero-Arenas M, Medina-Cuadros M, Martinez-Gallego G. Usefulness of intrinsic infection risk indexes as predictors of in-hospital death. Am J Infect Control 1997; 25:365-70.
74. Iezzoni LI. The risks of risk adjustment. JAMA 1997; 278:1600-7.
75. Wagner D, Draper E, Knaus W. APACHE III study design: analytic plan for evaluation of severity and outcome in intensive care unit patients. Development of APACHE III. Crit Care Med 1989; 17: S199-203.
76. Delgado-Rodriguez M, Sillero-Arenas M, Medina-Cuadros M, Martinez-Gallego G. Nosocomial infections in surgical patients: comparison of two measures of intrinsic patient risk. Infect Control Hosp Epidemiol 1997; 18:19-23.
77. Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286:1754-8.
78. Archibald LK, Gaynes RP. Hospital-acquired infections in the United States: the importance of interhospital comparisons. Infect Dis Clin North Am 1997; 11:245-55.
79. Jencks SF, Dobson A. Refining case-mix adjustment: the research evidence. N Engl J Med 1987; 317:679-86.
80. Schwartz M, Iezzoni LI, Moskowitz MA, Ash AS, Sawitz E. The importance of comorbidities in explaining differences in patient costs. Med Care 1996; 34:767-82.
81. Horn SD, Horn RA. The Computerized Severity Index: a new tool for case-mix management. J Med Syst 1986; 10:73-8.
82. Tierney WM, Fitzgerald JF, Miller ME, James MK, McDonald CJ. Predicting inpatient costs with admitting clinical data. Med Care 1995; 33:1-14.
83. Papazian L, Bregeon F, Thirion X, et al. Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med 1996; 154:91-7.
84. Thomas JW, Ashcraft ML. Measuring severity of illness: six severity systems and their ability to explain cost variations. Inquiry 1991; 28: 39-55.
85. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996; 276:1253-8.
86. Farber BF. Reimbursement for nosocomial infections under the prospective payment plan: the future or decline of infection control? Infect Control 1984; 5:425-6.
87. Revised ICD-9-CM DRG definitions manual, version 18.0. 18th ed. Murray, UT: 3M Health Information Systems, 2002.
88. Dunagan WC, Murphy DM, Hollenbeak CS, Miller SB. Making the business case for infection control: pitfalls and opportunities. Am J Infect Control 2002; 30:86-92.
89. Martone WJ, Jarvis W, Culver DH, Haley RW. Incidence and nature of endemic and epidemic nosocomial infections. In: Bennett JV, Brachman PS, eds. Hospital infections. Boston: Little, Brown, 1992:577-96.